EXFLUNAY
Live / Registered — Registered (as of 03 Feb 2026)
What this means for you
Registered since 03 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98892130
- Registration number
- 8123338
- Mark type
- Stylized text
- Filed
- 09 Dec 2024
- Published for opposition
- 16 Dec 2025
- Registered
- 03 Feb 2026
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases
Owner
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
Prosecution history
- 03 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 16 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Dec 2025 — PUBLISHED FOR OPPOSITION
- 10 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Oct 2025 — NON-FINAL ACTION E-MAILED
- 14 Oct 2025 — NON-FINAL ACTION WRITTEN
- 18 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Sept 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED